Laura Fisher
Royal Society of Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge, CB4 0WF, UK. E-mail: advances-rsc@rsc.org
First published on 22nd January 2021
Retraction of ‘FOXC1 silencing promotes A549 cell apoptosis through inhibiting the PI3K/AKT/hedgehog/Gli2 signaling pathway’ by Pei Wang et al., RSC Adv., 2018, 8, 33786–33793, DOI: 10.1039/C8RA06041J.
In Fig. 1 and 2, there is no apparent background to the western blots. In the raw data provided by the authors, some background is displayed, but it is not clear whether this is genuine. For the FOXC1 panel in Fig. 1 and the β-actin panel in Fig. 2, the area immediately around the bands in the raw data has a different appearance to the rest of the raw data, indicating that the row of bands may have been placed on a false background.
Analysis of the western blots in Fig. 4 shows that all 4 panels have the same background, indicating that these images have been manipulated.
Given the significance of the concerns about the validity of both the data in the article and the raw data provided by the authors, the findings presented in this paper are not reliable.
The authors have been informed but have not responded to any correspondence regarding the retraction.
Signed: Laura Fisher, Executive Editor, RSC Advances
Date: 7th January 2021
This journal is © The Royal Society of Chemistry 2021 |